ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,073,000 | +87.0% | 221,937 | +26.5% | 0.01% | +66.7% |
| Q4 2018 | $2,178,000 | -66.7% | 175,399 | -48.6% | 0.00% | -25.0% |
| Q3 2018 | $6,546,000 | +189.0% | 341,428 | +105.0% | 0.00% | +33.3% |
| Q2 2018 | $2,265,000 | +802.4% | 166,523 | +22.7% | 0.00% | – |
| Q1 2017 | $251,000 | +43.4% | 135,684 | +20.5% | 0.00% | – |
| Q4 2016 | $175,000 | -75.0% | 112,642 | +18.0% | 0.00% | -100.0% |
| Q3 2016 | $701,000 | +45.7% | 95,441 | +5.6% | 0.00% | 0.0% |
| Q2 2016 | $481,000 | – | 90,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |